What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
Read More
Discover how our symposium brought NHS and industry together to discuss the future of healthcare. We focused on innovation, collaboration, and transformation.
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Barcelona over the 18th–20th November 2024. Mtech Access experts will be joined by our colleagues from across Petauri, including...
Read More
What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...
Read More
Iain Shield (Associate Director – Market Access, Mtech Access) discusses updates to prescribing information (Clause 12) in the ABPI Code of Practice and the considerations for digital materials
Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of ‘willingness to pay’ (WTP). Read on to explore 4 factors that impact WTP and compare 5 methodologies for price testing with payers.
A symposium for UK market access leaders The healthcare landscape is continuously evolving, and the need for effective collaboration between the NHS and industry partners has never been more critical....
Read More
Louise Maddison joined Mtech Access as a Senior Consultant in our Market Access Team, earlier this year. Here, she talks about her career journey and her experiences since joining Mtech Access.
Discover how data visualisation dashboards can aid field teams in market access discussions with customers Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with...
Read More
Calum Jones (Associate Director – Health Economics) shares his experience speaking at the 2024 HTAi Conference. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations’.
